Loading stock data...

Vivanza Biosciences Limited

BSE: VIVANZA

BSE
2.10 0.03 (1.45%)

Prev Close

2.07

Open Price

2.04

Volume

16,242

Today Low / High

2.04 / 2.13

52 WK Low / High

1.9 / 4.9

Range

2 - 2

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 2.1, reflecting a change of 0.03 (1.44928%). The expected target range on the BSE is 2 - 2. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

22 Aug 2.04 2.94%
21 Aug 2.07 0.00%
20 Aug 2.11 -1.90%
19 Aug 2.08 3.37%
18 Aug 2.10 -0.95%
14 Aug 2.09 0.48%
13 Aug 2.10 -2.38%
12 Aug 2.12 -1.42%
11 Aug 2.14 -1.40%
08 Aug 2.00 5.00%
07 Aug 2.11 -3.32%
06 Aug 2.09 0.00%
05 Aug 2.10 -0.95%
04 Aug 2.09 -0.48%
01 Aug 2.08 -0.48%
31 Jul 2.04 0.00%
30 Jul 2.09 -1.44%
29 Jul 2.08 -1.92%
28 Jul 2.20 -6.36%

Vivanza Biosciences Limited Graph

Vivanza Biosciences Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Vivanza Biosciences Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 2.10, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 2.10 2.12 1.91 - 2.33
2.14 1.71 - 2.57
2.16 1.51 - 2.81
Bearish Scenario 2.10 2.08 1.87 - 2.29
2.06 1.65 - 2.47
2.04 1.43 - 2.65

Overview of Vivanza Biosciences Limited

ISIN

INE984E01035

Industry

Medical - Pharmaceuticals

Vol.Avg

67,708

Market Cap

84,000,000

Last Dividend

0

Official Website

Visit Website

IPO Date

DCF Diff

5.95

DCF

2

Financial Ratios Every Investor Needs

Stock Rating Details for VIVANZA

Metric Value Recommendation
Overall Rating C Sell
DCF Score 4 Buy
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 3 Neutral

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 7.42 Cr 6.82 Cr 0.60 Cr 0.0812 0.00 Cr 0.00 Cr -0.38 Cr -0.67 Cr -0.16 -0.30 Cr -0.0908
2024-03-31 27.84 Cr 25.95 Cr 1.88 Cr 0.0677 0.00 Cr 0.03 Cr 1.10 Cr 0.55 Cr 0.14 1.12 Cr 0.0197
2023-03-31 17.81 Cr 16.82 Cr 0.99 Cr 0.0556 0.00 Cr 0.25 Cr 0.69 Cr 0.60 Cr 0.15 1.14 Cr 0.0336
2022-03-31 10.40 Cr 9.92 Cr 0.49 Cr 0.0466 0.00 Cr 0.40 Cr 0.06 Cr 0.33 Cr 0.08 0.86 Cr 0.0320
2021-03-31 9.89 Cr 9.50 Cr 0.38 Cr 0.0389 0.00 Cr 0.25 Cr 0.10 Cr 0.08 Cr 0.02 0.29 Cr 0.0076

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 0.12 Cr 16.45 Cr 12.49 Cr 3.9641 Cr 8.65 Cr 8.54 Cr 2.26 Cr 0.70 Cr 0.00 Cr 0.00 Cr 0.00 Cr 9.1542 Cr
2024-03-31 0.17 Cr 19.50 Cr 14.86 Cr 4.6383 Cr 5.17 Cr 5.00 Cr 2.01 Cr 0.70 Cr 0.00 Cr 0.00 Cr 0.00 Cr 12.1811 Cr
2023-03-31 0.14 Cr 22.48 Cr 18.39 Cr 4.0910 Cr 8.00 Cr 7.86 Cr 2.70 Cr 0.68 Cr 0.66 Cr 0.00 Cr 0.61 Cr 16.9529 Cr
2022-03-31 0.06 Cr 15.56 Cr 12.07 Cr 3.4925 Cr 5.51 Cr 5.45 Cr 2.52 Cr 0.68 Cr 0.40 Cr 0.00 Cr 0.79 Cr 9.4729 Cr
2021-03-31 -3.09 Cr 8.45 Cr 5.29 Cr 3.1595 Cr 0.36 Cr 3.45 Cr 0.68 Cr 0.69 Cr 0.43 Cr 0.00 Cr 1.11 Cr 5.2882 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 -2.4990 Cr -0.0079 Cr 2.4570 Cr -2.5069 Cr -0.0499 Cr 0.1169 Cr -0.0079 Cr -0.6657 Cr 2.8085 Cr 0.0000 Cr -0.2568 Cr
2024-03-31 2.0439 Cr -0.0375 Cr -1.9804 Cr 2.0063 Cr 0.0260 Cr 0.1669 Cr -0.0375 Cr 0.5473 Cr -4.0768 Cr 0.0000 Cr 0.4683 Cr
2023-03-31 -0.2005 Cr 0.0000 Cr 0.2863 Cr -0.2005 Cr 0.0858 Cr 0.1409 Cr 0.0000 Cr 0.5983 Cr 2.4889 Cr 0.0000 Cr -0.0465 Cr
2022-03-31 -0.5353 Cr 0.0000 Cr 0.5251 Cr -0.5353 Cr 3.1478 Cr 0.0551 Cr 0.0000 Cr 0.3330 Cr 1.9926 Cr 0.0000 Cr -1.7746 Cr
2021-03-31 -3.2321 Cr -0.0211 Cr 2.9374 Cr -3.2532 Cr -0.3157 Cr -3.0927 Cr -0.0211 Cr 0.0753 Cr 0.1822 Cr 0.0000 Cr 0.3134 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-03-31 0.49 Cr 1.17 Cr -0.68 Cr -1.3878 -0.95 Cr -1.00 Cr -0.23 -0.91 Cr -2.0301
2024-12-31 1.50 Cr 1.11 Cr 0.39 Cr 0.2614 0.12 Cr 0.04 Cr 0.01 0.13 Cr 0.0289
2024-09-30 3.00 Cr 2.86 Cr 0.15 Cr 0.0484 0.11 Cr 0.02 Cr 0.00 0.11 Cr 0.0052
2024-06-30 2.44 Cr 1.82 Cr 0.62 Cr 0.2534 0.47 Cr 0.27 Cr 0.07 0.36 Cr 0.1088
2024-03-31 4.42 Cr 4.47 Cr -0.05 Cr -0.0104 -0.14 Cr -0.41 Cr -0.10 -0.16 Cr -0.0936

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-03-31 0.12 Cr 0.00 Cr 0.12 Cr 9.70 Cr 2.26 Cr 12.38 Cr 0.70 Cr 16.45 Cr 12.49 Cr
2024-12-31 0.00 Cr 0.00 Cr 0.17 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -4.92 Cr
2024-09-30 0.17 Cr 0.00 Cr 0.17 Cr 14.93 Cr 2.60 Cr 18.16 Cr 0.71 Cr 21.96 Cr 17.04 Cr
2024-06-30 0.00 Cr 0.00 Cr 0.20 Cr 0.00 Cr 0.00 Cr 0.20 Cr 0.00 Cr 0.00 Cr -4.64 Cr
2024-03-31 0.17 Cr 0.03 Cr 0.20 Cr 11.54 Cr 2.01 Cr 15.74 Cr 0.70 Cr 19.50 Cr 14.86 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-03-31 -1.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 0.04 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 0.02 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 0.27 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 -0.41 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
2023-03-27 March 27, 23 10:1
2015-08-20 August 20, 15 1:20

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹821.25 ₹98,339,283,675.00 ₹72,992.00

Key Executives

Managing Director & Executive Director
Mr. Jayendra A Mehta

Gender: male

Year Born: 1965

Company Secretary & Compliance Officer
Siddhi Shah

Gender: Not Specified

Year Born:

FAQs about Vivanza Biosciences Limited

Who is the CEO of the company?

The CEO is Jayendra A Mehta.

What is the current market price of the stock?

The current price is ₹2.10.

What is the 52-week price range?

The range is ₹1.9-4.9.

What is the market capitalization of the company?

The market capitalization is ₹8.40 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is -13.54.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Vivanza Biosciences Limited (ISIN: INE984E01035) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹8.40 crores and an average daily volume of 67,708 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.

Welcome to the Investing and Trading Information platform: InvesTrack.in

Note: This platform is for educational and informational purposes only. Do not consider anything as financial advice.

QUICK LINKS

Home
About us
Contact us
Privacy Policy
Disclaimer
Sitemap
Investing
Trading
Top Brokers
Tools
Live Analysis

STAY CONNECTED

Follow Us On Social Media
Get Latest Update On Social Media
Facebook Instagram Twitter

General Disclaimer: InvesTrack is an educational platform and not any type of investment advisory platform. Our Blog and videos are based on countless hours of research and experience, which you can use as a guide for your research purposes. None of our content should be considered a piece of investment advice. Earning Disclosure: InvesTrack is a community supported platform. We may earn a commission when you make a purchase through one of our links at no extra cost to you. Note: We are not SEBI Registered Advisors. This website is purely for training and educational purposes. We shall not be responsible for your profit or loss.

© Copyright 2024 - 2025 | InvesTrack